1887

oa South African Medical Journal - Type IIa hyperlipoproteinaemia - an evaluation of four therapeutic regimens

 

Abstract

The cholesterol-lowering effect of clofibrate (Ciba-SU13437) cholestyramine and the combination of clofibrate and cholestyramine is studied in 19 subjects with type IIa hyperlipoproteinaemia, over a 20-week period.

Loading

Article metrics loading...

/content/m_samj/49/15/AJA20785135_23724
1975-04-01
2016-12-04
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error